Bridgeway Capital Management »

Silverback Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $134k 20k 6.70
2023-03-31 $130k 20k 6.51
2022-12-31 $763k 89k 8.53
2022-09-30 $508k 96k 5.28
2022-06-30 $279k 66k 4.24
2022-03-31 $360k 103k 3.51